Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01153477 · ClinicalTrials.gov registry record · Phase 2
Effectiveness of Enhanced Treatments for Drug Dependence
A Phase 2 study of Cocaine Dependence, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Phase 2
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT01153477 is a Phase 2 study of Cocaine Dependence that has completed, run by University of Pennsylvania. The registered enrollment target is 150 participants, below the 295-participant average among 38 other Cocaine Dependence trials with a reported enrollment target (49% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01153477, a Phase 2 study of Cocaine Dependence, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this challenge grant is to conduct an initial test of a new, enhanced version of this protocol (telephone monitoring and counseling - enhanced, or TMAC-E), which has been modified to include the elements of our existing continuing care intervention plus patient-centered changes to boost patient involvement and community linkages. The investigators will recruit 150 cocaine dependent patients in publicly funded, community-based programs and randomize them to treatment as usual or the TMAC-E and follow them for 12 months.
Conditions Studied
Interventions
- BEHAVIORAL Telephone Monitoring and Counseling - Enhanced
Study Locations (1)
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2009-10 |
| Est. Completion | 2011-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01153477
The ClinicalTrials.gov registry entry for NCT01153477 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 295-participant average among 38 other Cocaine Dependence trials with a reported enrollment target (49% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cocaine Dependence appearing as the primary indexed condition, and to 1 intervention - of which Telephone Monitoring and Counseling - Enhanced is the first listed.
NCT01153477 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01153477 about?
NCT01153477 is a clinical study titled "Effectiveness of Enhanced Treatments for Drug Dependence". The purpose of this challenge grant is to conduct an initial test of a new, enhanced version of this protocol (telephone monitoring and counseling - enhanced, or TMAC-E), which has been modified to include the elements of our existing continuing care intervention plus patient-centered changes to boo...
What is the current status of trial NCT01153477?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 150 participants. The study started on 2009-10. Estimated completion is 2011-10.
What conditions does trial NCT01153477 study?
This clinical trial studies the following conditions: Cocaine Dependence.
What interventions are being tested in trial NCT01153477?
The interventions under investigation include: Telephone Monitoring and Counseling - Enhanced (BEHAVIORAL).
Who is sponsoring clinical trial NCT01153477?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01153477 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cocaine Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Clavulanic Acid for the Treatment of Cocaine Use Disorder
ACTIVE NOT RECRUITING · Phase 2
-
Glutamatergic Modulation of Cocaine-related Deficits
COMPLETED · Phase 2
-
Disulfiram for Cocaine Abuse
COMPLETED · Phase 2
-
Multicenter Trial of Combined Pharmacotherapy to Treat Cocaine Dependence
COMPLETED · Phase 2
-
Citalopram for Cocaine Dependence
COMPLETED · Phase 2
-
PHASE IIA: Trial of a Novel Ondansetron Formulation (OND-PR002) and Immediate-Release Methylphenidate (Ritalin®)(OND003IND)
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.